In this file photo a health worker shows a bottle of Ivermectin, a medicine authorized by the National Institute for Food and Drug Surveillance (INVIMA) to treat patients with mild, asymptomatic or suspicious COVID-19, as part of a study of the Center for Paediatric Infectious Diseases Studies, in Cali, Colombia, on July 21, 2020. (LUIS ROBAYO / AFP via Getty Images)
Chicago’s Resurrection Medical Center resists pressure to provide unauthorized ivermectin treatment for COVID-19
Prepare Now Before its too Late
Discover where products are available & compare prices
